MORGAN STANLEY - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$1,279,165
-16.5%
420,778
-9.7%
0.00%
Q2 2023$1,532,524
-7.3%
465,813
-10.4%
0.00%
Q1 2023$1,652,510
-71.3%
519,657
-37.7%
0.00%
-100.0%
Q4 2022$5,767,737
+92.6%
833,488
+76.3%
0.00%
Q3 2022$2,994,000
+11.4%
472,876
-27.2%
0.00%
Q2 2022$2,687,000
-64.8%
649,266
-58.7%
0.00%
-100.0%
Q1 2022$7,628,000
+56.7%
1,572,805
+222.9%
0.00%0.0%
Q4 2021$4,867,000
-13.5%
487,080
+65.4%
0.00%0.0%
Q3 2021$5,629,000
-74.3%
294,572
-57.0%
0.00%
-66.7%
Q2 2021$21,899,000
+81.0%
684,780
+70.7%
0.00%
+50.0%
Q1 2021$12,098,000
-50.9%
401,263
-29.6%
0.00%
-50.0%
Q4 2020$24,655,000
+97.7%
569,813
+146.5%
0.00%
+100.0%
Q3 2020$12,471,000
+128.1%
231,135
+158.0%
0.00%
+100.0%
Q2 2020$5,468,000
-61.7%
89,585
-71.2%
0.00%
-75.0%
Q1 2020$14,283,000
+314.7%
310,752
+691.8%
0.00%
+300.0%
Q4 2019$3,444,000
-13.8%
39,247
-9.9%
0.00%0.0%
Q3 2019$3,997,000
-67.2%
43,542
-54.5%
0.00%
-66.7%
Q2 2019$12,176,000
-63.2%
95,720
-54.5%
0.00%
-66.7%
Q1 2019$33,070,000
+36.2%
210,198
-14.1%
0.01%
+28.6%
Q4 2018$24,287,000
-39.8%
244,827
-11.4%
0.01%
-30.0%
Q3 2018$40,362,000
-9.3%
276,460
-2.5%
0.01%
-16.7%
Q2 2018$44,508,000
-31.8%
283,575
-25.8%
0.01%
-33.3%
Q1 2018$65,225,000
+152.0%
381,987
+162.8%
0.02%
+157.1%
Q4 2017$25,884,000
+70.6%
145,331
+31.6%
0.01%
+40.0%
Q3 2017$15,172,000
+35.3%
110,461
+3.5%
0.01%
+66.7%
Q2 2017$11,210,000
-21.7%
106,716
-32.2%
0.00%
+50.0%
Q1 2017$14,310,000
-20.9%
157,430
-46.3%
0.00%
-33.3%
Q4 2016$18,102,000
+425.5%
293,368
+477.2%
0.00%
+200.0%
Q3 2016$3,445,000
+182.1%
50,822
+80.4%
0.00%
Q2 2016$1,221,000
-60.9%
28,177
-61.6%
0.00%
-100.0%
Q1 2016$3,119,000
-3.4%
73,376
+45.9%
0.00%0.0%
Q4 2015$3,230,000
-6.2%
50,291
+24.9%
0.00%0.0%
Q3 2015$3,444,000
-74.3%
40,256
-49.4%
0.00%
-80.0%
Q2 2015$13,389,000
+328.7%
79,520
+207.5%
0.01%
+400.0%
Q1 2015$3,123,000
-9.6%
25,863
-31.4%
0.00%0.0%
Q4 2014$3,456,000
-7.1%
37,683
-63.7%
0.00%0.0%
Q3 2014$3,720,000
+406.8%
103,700
+445.0%
0.00%
Q2 2014$734,000
+39.0%
19,027
-18.0%
0.00%
Q1 2014$528,000
+543.9%
23,214
+490.4%
0.00%
Q4 2013$82,000
-76.4%
3,932
-69.5%
0.00%
Q3 2013$347,00012,8840.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders